Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study

dc.contributor.authorAkbay, Gulsen Delikanli
dc.contributor.authorKarakullukcu, Erdinc
dc.contributor.authorMutlu, Asli Akyol
dc.contributor.authorBesler, Halit Tanju
dc.date.accessioned2026-02-06T18:21:44Z
dc.date.issued2019
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractObjective: Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. Lipid profile and anchropomecric measurements might differ for patients with MS and healthy people. This study aimed to compare the lipid profiles and anthropometric measurements of patients with MS and healthy participants. Materials and Methods: The study was designed as a controlled descriptive study, consisting of 392 people (196 patients in the MS-MS group, and 196 healthy volunteers in the control group) who presented to a state hospital in Turkey. Blood samples were collected and lipid profiles (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides) were analyzed. Body mass index (BMI), waist-to-hip and waist-to-height ratios were calculated, and the parameters were compared between the groups. The relationship between the parameters and the presence of MS was investigated. Results: The weights, heights, hip circumferences, waist-to-hip and waist-to-height ratios of the people differed statistically significantly between the groups (p<0.05). There were no statistically significant differences between the groups in terms of the considered lipid profiles. The difference between the BMI values of males in the control and MS groups was statistically significant (p=0.006). Conclusion: The obtained results indicate that anthropometric measurements of patients with MS differ significantly from healthy individuals, although no significant difference could be observed in terms of lipid profiles. Most of the findings of this study are consistent with the literature and suggest that the anthropometric changes in individuals should be followed regularly to prevent a possible MS risk.
dc.identifier.doi10.4274/tnd.galenos.2019.33341
dc.identifier.endpage228
dc.identifier.issn1301-062X
dc.identifier.issn1309-2545
dc.identifier.issue4
dc.identifier.orcid0000-0003-1366-4685
dc.identifier.orcid0000-0001-8805-1694
dc.identifier.orcid0000-0002-6523-7995
dc.identifier.scopus2-s2.0-85077987070
dc.identifier.scopusqualityQ4
dc.identifier.startpage218
dc.identifier.trdizinid334933
dc.identifier.urihttps://doi.org/10.4274/tnd.galenos.2019.33341
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/334933
dc.identifier.urihttps://hdl.handle.net/11129/9460
dc.identifier.volume25
dc.identifier.wosWOS:000504056300005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherTurkish Neurological Soc
dc.relation.ispartofTurkish Journal of Neurology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260204
dc.subjectMultiple sclerosis
dc.subjectlipid profile
dc.subjectanthropometric measurement
dc.titleDetermination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study
dc.typeArticle

Files